Speaker illustration

Doctor Juan Cosin Sales

HOSPITAL ARNAU DE VILANOVA, Valencia (Spain)

Member of:

European Society of Cardiology

Real vs perceived LDL cholesterol control in clinical practice in Spain: Which factors are related to real control?

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (3)

Thumbnail

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities

Thumbnail

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities

Thumbnail

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities

Thumbnail

An observational, international, cohort study to evaluate the satisfaction and preferences of patients in preventive treatment of secondary cardiovascular events with a cardiovascular polypill

Event: ESC Congress 2019

Topic: Health Economics

Session: Health economics and policy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb